Stem cells for the treatment of neurodegenerative diseases.
about
Neural stem/progenitor cells in Alzheimer's diseaseGeneration of diverse neural cell types through direct conversionCryopreservation of Human Stem Cells for Clinical Application: A ReviewMesenchymal Stem Cells Preserve Working Memory in the 3xTg-AD Mouse Model of Alzheimer's Disease.Nutraceuticals against Neurodegeneration: A Mechanistic Insight.Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an AβPP/PS1 transgenic mouse model.Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple SclerosisPromoting effects of isobavachin on neurogenesis of mouse embryonic stem cells were associated with protein prenylation.Stem cell technology for the study and treatment of motor neuron diseases.Generation and applications of human pluripotent stem cells induced into neural lineages and neural tissues.Regenerative medicine in Alzheimer's disease.ADSC therapy in neurodegenerative disorders.The human urinary exosome as a potential metabolic effector cargo.Blastema cells derived from New Zealand white rabbit's pinna carry stemness properties as shown by differentiation into insulin producing, neural, and osteogenic lineages representing three embryonic germ layers.Isolation, characterization, and differentiation of progenitor cells from human adult adrenal medulla.Adrenomedullin as a growth and cell fate regulatory factor for adult neural stem cells.Adenosine triphosphate prevents serum deprivation-induced apoptosis in human mesenchymal stem cells via activation of the MAPK signaling pathways.Cholinergic and dopaminergic neuronal differentiation of human adipose tissue derived mesenchymal stem cells.Transplantation of Human Neural Progenitor Cells Reveals Structural and Functional Improvements in the Spastic Han-Wistar Rat Model of Ataxia.A Quartz Crystal Microbalance Immunosensor for Stem Cell Selection and Extraction.Senile Dementia from Neuroscientific and Islamic Perspectives.The Use of Autologous Mesenchymal Stem Cells for Cell Therapy of Patients with Amyotrophic Lateral Sclerosis in Belarus.Reprogramming of mouse fibroblasts into neural lineage cells using biomaterials.
P2860
Q26738352-81913BF3-62E4-4CC5-93AD-9B05919DCC94Q26765258-C8FFF3B2-066F-4565-88DF-8A21A1F644ACQ34939259-473A2C7C-EFC7-4AEC-AEF4-D7BC94E17676Q36666929-CA28982F-C771-416C-B782-29454275F5D8Q37168739-AD280CD8-4003-4357-8880-CE39ED2EA1DCQ37372219-ADE721B0-AD2E-4513-99C1-93DD4D794D2FQ37502636-E5828BEB-E212-46D4-8C72-34B11A3F7B91Q37727440-2EEA0463-02D3-4BDB-861B-E5B03DF0BE70Q37851503-DA4F8126-3AD6-4581-B73A-4495913F45B2Q37998022-4B824B43-C075-409B-8534-AE4082EF7041Q38167135-3F4D3527-7FFB-4689-BA62-28DF1D1CAB78Q38210872-BAEE2B1B-F9B5-48D6-BE06-D080B27FE767Q38460526-68726968-85EF-4B8E-B215-7F5B4414DD8CQ40674950-CB2FC7BA-A72E-443F-9B7B-6C0F295C6DCAQ40881051-C59135C7-0A7F-4C87-8F2C-8BD3E41CFECBQ41828169-FED4B270-671E-437C-BDF4-3EB822358DD4Q42194108-267B9852-7A4D-41C1-B5A2-5B88980B46FFQ45056222-126FBA17-41B7-435E-AD05-31ED4A4EC849Q47729707-CA50A68E-0898-4678-9087-B9E9005B0537Q48223593-0750BD41-4EF0-4DA3-A57A-EB61863E53D5Q50885299-846C170D-CA34-4A1E-9A3A-D2555A0D931AQ53336346-E32E7B5C-27CD-4B34-A56C-971750486746Q55446282-62FA0351-4C63-41B7-AF15-0DF0FBF7593A
P2860
Stem cells for the treatment of neurodegenerative diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Stem cells for the treatment of neurodegenerative diseases.
@en
Stem cells for the treatment of neurodegenerative diseases.
@nl
type
label
Stem cells for the treatment of neurodegenerative diseases.
@en
Stem cells for the treatment of neurodegenerative diseases.
@nl
prefLabel
Stem cells for the treatment of neurodegenerative diseases.
@en
Stem cells for the treatment of neurodegenerative diseases.
@nl
P2860
P356
P1476
Stem cells for the treatment of neurodegenerative diseases
@en
P2093
Elise Dantuma
Stephanie Merchant
P2860
P2888
P356
10.1186/SCRT37
P577
2010-12-10T00:00:00Z
P5875
P6179
1017222493